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Over the past decades, colonoscopy has evolved from a purely 
diagnostic procedure to one that currently encompasses increasingly 
complex therapeutic interventions. The catalyst of this evolution 
was the adoption of screening colonoscopy for the prevention of 
colorectal cancer in the average-risk population. The advent of 
screening colonoscopies in healthy individuals also brought the need 
to monitor the safety and effectiveness of the procedure to the fore. 
In the UK, these goals are achieved through high-quality training 
and effective audits of the performance of trainees and practising 
clinicians, using direct observations of procedural skills (DOPS) 
assessment for the former, and key performance indicators (KPIs) 
for both. The main KPIs for colonoscopy are caecal intubation 
rate (CIR >90%), withdrawal time (>6 minutes), quality of 
bowel preparation (>90% (adequate)) and adenoma detection 
rate (ADR >15%).[1-3] Although these parameters are assessed 
individually, they are interdependent.
In South Africa (SA), there are only 102 gastroenterologists and 
<20 colorectal surgeons for whom colonoscopy is a core competency. 
Consequently, a much smaller proportion of colonoscopies are 
perfomed by these specialists than in Europe and North America. 
The majority of colonoscopies outside the eight university 
gastroenterology training units are performed by general surgeons, 
who receive no structured training in the procedure as registrars. 
For example, in public hospitals in KwaZulu-Natal Province in 2016, 
general surgeons and surgical medical officers constituted 90% (72/89) 
of active endoscopists, while there were only 0.06 gastroenterologists 
(medical, and the surgical subspecialties) per 100 000 people.[4] In the 
private sector in SA, which covers a population of just <9 million with 
medical insurance, 150 000 colonoscopies are performed annually, 
mostly by general surgeons (66%), followed by gastroenterologists 
(20%) and physicians (14%).[5] In contrast, only 70 000 colonoscopies 
are performed in the ~50 million uninsured individuals who utilise 
state hospitals.[5] The quality of the colonoscopy performed by the 
different practitioners in SA is probably highly varied and largely 
unknown.
In this issue of SAMJ, two studies for the first time report 
information assessing the quality of colonoscopy in the public and 
private sectors.[6,7] It is heartening that the CIR in both studies meets 
international targets. However, the proportion of examinations 
with adequate bowel preparation falls short of recommendations. 
Improving bowel preparation requires focused attention across the 
country, and can be improved by the use of split-dose preparations 
and ensuring appropriate delivery of instructions, reinforced by 
the use of mobile applications. These interventions should be 
underpinned by ongoing clinical audits, given the critical role bowel 
preparation plays in delivering quality colonoscopy. 
Whereas the CIR measures the performance of the individual 
practitioner, and can be reliably used across populations, the ADR is 
dependent on the prevalence of colonic adenomas (colorectal cancer 
precursor lesions) in a population. The frequency of colorectal cancer 
in SA varies with ethnicity, being highest in the white and lowest in 
the black population.[8] Therefore, theoretically, the target ADR in SA 
should vary according to the population under consideration, and 
it is important that this parameter be benchmarked in the various 
ethnic groups in the country. 
At the Wits Donald Gordon Medical Centre (WDGMC), a private 
hospital, the average ADR was 15.6% (107/686) in a prospective audit 
of 1 643 colonoscopies.[6] When disaggregated by ethnicity, the ADR 
was 15.3% (83/543) in white patients, 17.6% (13/74) in Asians and 
18.5% (10/54) in black patients.[6] This study did not state whether 
individuals at high risk of colorectal adenomas (strong family 
history, adenomatous syndromes, previous colorectal cancer) were 
excluded, which may explain the higher than expected ADR in the 
black population. In contrast, the second study, from an academic 
state institution, Groote Schuur Hospital, Cape Town, reviewed 
992 colonoscopies in people at average risk of colorectal cancer.[7] 
The ADR in this study was 12% (18% in white and Asian patients 
(16/103 and 2/13, respectively), 13% (95/757) in the mixed-race 
population and 5% (6/119) in black South Africans). Although 
these studies are hospital based, and not truly reflective of the 
typical healthy adult population for which ADR is regarded as the 
benchmark, they provide a solid basis for clinical practice in SA 
and the rest of Africa. From the findings, a clinician providing 
quality colonoscopy to a diverse population in SA should achieve 
a minimum ADR of 12 - 15%, which is comparable with targets 
elsewhere. 
There was a wide disparity in the ADR in the black population 
between the two studies. The ADR in the black population in the 
study at Groote Schuur Hospital was 5%, and is similar to findings 
from elsewhere on the continent.[9,10] The ADR in the study from 
WDGMC (18.5%) was much higher, which suggests a selection bias. 
Worryingly, the number of black South Africans who had undergone 
colonoscopies in the two studies was low, possibly reflecting the 
underlying catchment populations of these two hospitals. Therefore, 
it is premature to make definitive conclusions on the prevalence 
of colorectal adenomas in the black population, and adequately 
powered population-based studies are required. Until these are 
available, the decision to offer a screening colonoscopy in the black 
population should be individualised, taking into account lifestyle and 
comorbid conditions, particularly diabetes mellitus, the metabolic 
syndrome and obesity. Diabetes mellitus was a key risk factor for 
colorectal cancer in the black population in a case-control study 
performed in Zimbabwe.[11]
Although a formal, national population-based screening 
programme for colorectal neoplasia is probably not currently 
justifiable in SA, the well-resourced private sector serving people 
who have health insurance provides opportunities for structured 
exploratory programmes. Interestingly, the majority of the white 
population, who have a high incidence of colorectal cancer and 
are likely to derive the most benefit from screening, have health 
insurance coverage. A project is currently being rolled out – a faecal 
immunochemical test (FIT) trial – as a triage tool for average-risk 
patients >50 years of age, which will also monitor the quality of 
colonoscopy in those who test positive. This should also be used to 
generate data for future public health programmes. In the academic 
state sector, targeted screening and surveillance occur haphazardly 
for familial cancers; these require a national co-ordinated response, as 
does the use of FITs. A national electronic record system of endoscopic 
procedures can help to facilitate such data collection and standardise 
practice. It should include a registry for familial colorectal cancers, as 
systematic screening provides undoubted mortality benefits for these 
individuals.[12] Expanding endoscopy registries should be a priority 
and will inform health policy on colonoscopy provision, screening 
and surveillance strategies. 
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